Genfit Operating Margin from 2010 to 2024
| GNFT Stock | USD 4.20 0.04 0.94% |
Check Genfit financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genfit's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 4.1 M or Selling General Administrative of 11.1 M, as well as many indicators such as Price To Sales Ratio of 5.87, Dividend Yield of 0.0 or PTB Ratio of 2.47. Genfit financial statements analysis is a perfect complement when working with Genfit Valuation or Volatility modules.
Genfit | Operating Margin |
Latest Genfit's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Genfit over the last few years. It is Genfit's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genfit's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.51 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Genfit Operating Margin Regression Statistics
| Arithmetic Mean | (118.08) | |
| Coefficient Of Variation | (233.24) | |
| Mean Deviation | 167.14 | |
| Median | (4.61) | |
| Standard Deviation | 275.41 | |
| Sample Variance | 75,850 | |
| Range | 1K | |
| R-Value | (0.06) | |
| Mean Square Error | 81,384 | |
| R-Squared | 0 | |
| Significance | 0.83 | |
| Slope | (3.74) | |
| Total Sum of Squares | 1.1M |
Genfit Operating Margin History
About Genfit Financial Statements
Genfit shareholders use historical fundamental indicators, such as Operating Margin, to determine how well the company is positioned to perform in the future. Although Genfit investors may analyze each financial statement separately, they are all interrelated. The changes in Genfit's assets and liabilities, for example, are also reflected in the revenues and expenses on on Genfit's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France. Genfit SA operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 134 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Genfit Stock Analysis
When running Genfit's price analysis, check to measure Genfit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genfit is operating at the current time. Most of Genfit's value examination focuses on studying past and present price action to predict the probability of Genfit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genfit's price. Additionally, you may evaluate how the addition of Genfit to your portfolios can decrease your overall portfolio volatility.